Petrus Trust Company LTA Purchases 8,398 Shares of Addus HomeCare Corporation $ADUS

Key Points

• Petrus Trust Company LTA significantly increased its stake in Addus HomeCare by 494.6%, owning 10,096 shares valued at approximately $998,000.
• Wall Street analysts generally view Addus HomeCare positively, with several firms upgrading their ratings and setting target prices between $133.00 and $150.00.
• Addus HomeCare reported a quarterly earnings per share of $1.49, surpassing estimates, while its revenue grew 21.8% year-over-year to $349.44 million.

Petrus Trust Company LTA grew its stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 494.6% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 10,096 shares of the company's stock after acquiring an additional 8,398 shares during the period. Petrus Trust Company LTA owned about 0.05% of Addus HomeCare worth $998,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Premier Fund Managers Ltd purchased a new stake in Addus HomeCare during the 1st quarter worth approximately $726,000. Deutsche Bank AG increased its stake in Addus HomeCare by 50.0% during the 4th quarter. Deutsche Bank AG now owns 16,354 shares of the company's stock worth $2,050,000 after buying an additional 5,448 shares during the period. Bank of America Corp DE increased its stake in Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after buying an additional 128,211 shares during the period. HighTower Advisors LLC increased its stake in Addus HomeCare by 62.4% during the 1st quarter. HighTower Advisors LLC now owns 4,671 shares of the company's stock worth $462,000 after buying an additional 1,795 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main increased its stake in Addus HomeCare by 77.6% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 8,836 shares of the company's stock worth $1,108,000 after buying an additional 3,862 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on ADUS shares. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research note on Sunday, June 29th. Macquarie reaffirmed an "outperform" rating and issued a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. Barclays lifted their target price on shares of Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a report on Tuesday, August 19th. TD Cowen boosted their price objective on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Finally, Royal Bank Of Canada boosted their price objective on shares of Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research note on Friday, August 22nd. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $138.89.

Insider Buying and Selling

In other news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the transaction, the director directly owned 5,067 shares of the company's stock, valued at approximately $582,350.31. This trade represents a 23.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the transaction, the chief executive officer directly owned 166,461 shares of the company's stock, valued at $19,134,691.95. The trade was a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 34,310 shares of company stock valued at $3,958,375. 4.50% of the stock is owned by company insiders.

Addus HomeCare Stock Performance

Shares of ADUS traded down $1.31 during trading hours on Tuesday, reaching $113.05. 146,437 shares of the company's stock traded hands, compared to its average volume of 131,675. The business's fifty day simple moving average is $112.00 and its two-hundred day simple moving average is $107.00. The firm has a market capitalization of $2.08 billion, a price-to-earnings ratio of 24.96, a P/E/G ratio of 1.74 and a beta of 0.85. Addus HomeCare Corporation has a twelve month low of $88.96 and a twelve month high of $136.72. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million during the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The firm's quarterly revenue was up 21.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.35 EPS. Analysts predict that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.